It’s looking more likely that Active Implants will fail again in getting its knee implant on the US market.
The US Food and Drug Administration’s Orthopedic and Rehabilitation Devices Panel of the Medical Devices Advisory Committee voted 6 to...
Rejected Again: Advisory Panel Votes Against De Novo Approval For Tennessee Company’s Knee Implant
An FDA advisory committee voted against recommending the agency approve a de novo request from Active Implants for its NUsurface Meniscus Implant. The request is the company’s fifth attempt at winning FDA approval.
